Tuanli Li

Case Report: Anlotinib Therapy in a Patient With Recurrent and Metastatic RAIR-DTC Harboring Coexistent TERT Promoter and BRAFV600E Mutations

J. Qian, Ling Zhang, Ying Zhang, 2021, Frontiers in Oncology.